Heterotransplantation of Human Lymphoid Neoplasms Using a Nude Mouse Intraocular Xenograft Model

Cancer Research

Volumn 50, Issue 10, 1990, Pages 3078-3086

  White, Les ^a,b   Norris, Murray D ^a   Marshall, Glenn M ^a   Stewart, Bernard W ^a,b   Tobias, Vivienne ^a   Sosula, Leo ^a   Trickett, Annette ^b  

^a SYDNEY CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B CELL LEUKEMIA; B CELL LYMPHOMA; CELL LINE; CHILD; CLINICAL ARTICLE; FEMALE; GENE REARRANGEMENT; HISTOLOGY; HUMAN; HUMAN CELL; INFANT; MALE; MOUSE; PRIORITY JOURNAL; TUMOR XENOGRAFT; ULTRASTRUCTURE;

ANIMAL; ANTERIOR CHAMBER; BLOTTING, SOUTHERN; DISEASE MODELS, ANIMAL; GENE REARRANGEMENT, B-LYMPHOCYTE; GENE REARRANGEMENT, BETA-CHAIN T-CELL ANTIGEN RECEPTOR; HUMAN; LEUKEMIA, LYMPHOCYTIC; LYMPHOMA, NON-HODGKIN; MICE; MICE, NUDE; MICROSCOPY, ELECTRON; NEOPLASM TRANSPLANTATION; SUPPORT, NON-U.S. GOV'T; TRANSPLANTATION, HETEROLOGOUS;

EID: 0025337230     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Watanabe, S., Shimosato, Y., and Kameya, T. Leukemic distribution of a human acute lymphocytic leukemia cell line (Ichikawa strain) in nude mice conditioned with whole-body irradiation. Cancer Res., 38:3494–3498, 1978.
2. Watanabe, S., Shimosato, Y., and Kuroki, M. Transplantability of human lymphoid cell line, lymphoma, and leukemia in splenectomized and/or irradiated nude mice. Cancer Res., 40: 2588–2595, 1980.
3. Blythman, H. E., Bord, A., Buisson, I., Thurneyssen, O., Richer, G., and Jansen, F. K. The nude mouse for the study of immunotoxins. In: B. Winograd, M. J. Peckham, and H. M. Pinedo, (eds.), Human Tumor Xenografts in Anticancer Drug Development, pp. 103–110. Berlin: Springer-Verlaag, 1988.
4. Sordillo, P. P., Hansen, H., Jhanwar, S. C., Beck, J., Lieberman, P., and Helson, L. Human hematopoietic tumors in nude mice. Exp. Cell Biol., 49: 256–266, 1981.
5. Arione, R., Jemma, C., Forni, M., Marchese, C., Benetton, G., Giubellino, C., Modesti, A., Martinotti, M., Montezemolo, L., Musso, T., and Forni, G. A. New childhood T-cell lymphoma established in nude mice and in vitro. Cancer Res., 48: 1312–1318, 1988.
6. Dillman, R. O., Johnson, D. E., Shawler, D. L., Halpern, S. E., Leonard, J. E., and Hagan, P. L. Athymic mouse model of a human T-cell tumor. Cancer Res., 45: 5632–5636, 1985.
7. Chomienne, C., Chedeville, A., Balitrand, N., De Cremoux, P., Abita, J., and Degos, L. Discrepancy between in vitro and in vivo passaged U-937 human leukemic cells: tumorigenicity and sensitivity to differentiating drugs. In Vivo, 2:281–288, 1988.
8. Ferrero, D., and Rovera, G. Human leukemic cell lines. Clin. Haematol., 13: 461–487, 1984.
9. White, L. Establishment of leukaemic cell lines by xenografting. Cancer Forum, 13: 59–60, 1989.
10. Martin, P. J., Giblett, E. R., and Hansen, J. A. Phenotyping human leukemic T-cell lines: enzyme markers, surface antigens, and cytogenetics. Immuno-genetics, 75: 385–398, 1982.
11. Lange, B., Valtieri, M., Santoli, D., Caracciolo, D., Mavilio, F., Gemperlein, I., Griffin, C., Emanuel, B., Finan, J., Nowell, P., and Rovera, G. Growth factor requirements of childhood acute leukemia: establishment of GM-CSF-dependent cell lines. Blood, 70: 192–199, 1987.
12. Naeim, F., Jensen, J. A., and Gatti, R. A. Does the established cell line represent the original leukemia clone? Proc. Am. Assoc. Cancer Res., 29: 211, 1988.
13. Allouche, M., Georgoulias, V., Bourinbalar, A., Dupuy I., Clemenceau, C., Gaget, H., Mathe, G., and Jasmin, C. Abnormal proliferation of T-colony-forming cells from peripheral blood of patients with T-cell acute lymphoblastic leukemias and lymphomas in complete remission: potential prognostic value. Br. J. Haematol., 65:411–418, 1987.
14. Campanile, F., Crino, L., and Bonmassar, E. Radioresistant inhibition of lymphoma growth in congenitally athymic (nude) mice. Cancer Res., 37: 394–398, 1977.
15. Martinotti, M. G., Arione, R., Foa, R., Pegoraro, L., Jemma, C., and Forni, G. Serial transplantation of a human acute T lymphoblastic leukemia into nude mice. Tumori, 72: 553–558, 1986.
16. Ohsugi, Y., Gershwin, M. E., Owens, R. B., and Nelson-Rees, W. A. Tumorigenicity of human malignant lymphoblasts: comparative study with unmanipulated nude mice, antilymphocyte serum-treated nude mice, and X-irradiated nude mice. J. Natl. Cancer Inst., 65: 715–718, 1980.
17. Ziegler, H. W., Frizzera, G., and Bach, F. H. Successful transplantation of a human leukemia cell line into nude mice: conditions optimizing graft acceptance. J. Natl. Cancer Inst., 68: 15–18, 1982.
18. Leonard, J. E., Johnson, D. E., Felsen, R. B., Tanney, L. E., Royston, I., and Dillman, R. O. Establishment of a human B-cell tumor in athymic mice. Cancer Res., 47: 2899–2902, 1987.
19. Schaadt, M., Kirchner, H., and Fonatsch, C. Intracranial heterotransplantation of human hematopoietic cells in nude mice. Int. J. Cancer, 23:751–761, 1979.
20. Gallie, B. L., Albert, D. M. Wong, J. J. Y., Buyukmihei, N., and Puliafito, C. A. Heterotransplantation of retinoblastoma into the athymic “nude” mouse. Invest. Ophthalmol. Vis. Sci., 16: 256–259, 1977.
21. White, L., Gomer, C J., Doiron, D. R., and Szirth, B. C. Ineffective photodynamic therapy (PDT) in a poorly vascularized xenograft model. Br. J. Cancer, 57:455–458, 1988.
22. White, L., Szirth, B. C., and Benedict, W. F. Evaluation of response to chemotherapy in retinoblastoma heterotransplanted to the eyes of nude mice. Cancer Chemother. Pharmacol., 23:63–67, 1989.
23. White, L., Reed, C., and Tobias, V. Comparison of cyclophosphamide and diaziquone in retinoblastoma xenograft model. Ophthal. Paediatr. Genet., 70:99–105, 1989.
24. White, L., Meyer, P. R., and Benedict, W. F. Establishment and characterisation of a human T-cell leukemia line (LALW-2) in nude mice. J. Natl. Cancer Inst., 72: 1029–1038, 1984.
25. White, L., Haber, M., Brian, M. J., Trickett, A., Susula, L., Tiley, C., and Stewart, B. W. Therapy induced drug resistance in a human leukemia line (LALW-2): a clinically relevant model. Cancer (Phila.), 63: 21–28, 1989.
26. Cordell, J. L., Falini, B., and Erber, W. N. Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J. Histochem. Cytochem., 32: 219–229, 1984.
27. Hsu, S. M., Raine, L., and Fanger, H. The use of avidin biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J. Histochem. Cytochem., 29:577–580, 1981.
28. Ravetch, J. V., Siebenlist, U., Korsmeyer, S., Waldmann, T., and Leder, P. Structure of the human immunoglobulin p locus: characterization of embryonic and rearranged J and D genes. Cell, 27: 583–591, 1981.
29. Heiter, P. A., Maizel, J. V., and Leder, P. Evolution of human immunoglobulin k J region genes. J. Biol. Chem., 257: 1516–1522, 1982.
30. Yanagi, Y., Yoshikai, Y., Legge, K., Clark, S. P., Aleksander, I., and Mak, T. W. A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains. Nature (Lond.), 308: 145–149, 1984.
31. Andiman, W., Gradoville, L., Heston, L., Neydorff, R., Savage, M. E., Kitchingman, G., Shedd, D., and Miller, G. Use of cloned probes to detect Epstein-Barr viral DNA in tissues of patients with neoplastic and lympho-proliferative diseases. J. Infect. Dis., 148: 967–977, 1983.
32. Boehm, T., Buluweha, L., Williams, D., White, L., and Rabbitts, T. H. A cluster of chromosome 11 p13 translocations found via distinct D-D and D-D-J rearrangements of the human T-cell receptor chain gene. EMBO J., 7: 2010–2017, 1988.
33. Stewart, B. W., Haber, M., de Montfort, M., and White, L. DNA mediated transfer of drug resistance from human leukemia cells. In: K. Lapis and S. Eckhardt (eds.), Novel Approaches in Cancer Therapy, pp. 123–128. Basel: S. Karger AG, 1987.
34. Haber, M., Norris, M. D., Kavallaris, M., Bell, D. R., White, L., and Stewart, B. W. Atypical multidrug resistance in a therapy-induced drug resistant human leukemia line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein. Cancer Res., 49: 5281–5287, 1989.
35. Genski, L. J., Lampkin, B. C., Goh, T. S., Dinndorf, P., Hake, D. A., Soukup, S., Jones, M. M., and Ballard, E. T. Immunologic, morphologic and chromosomal characterization of a cell line (TC78) established from a child with acute lymphoblastic leukemia. Leuk, Res., 9: 1497–1506, 1985.
36. Cross, A. H., Goorha, R. M., Nuss, R., Behm, F. G., Murphy, S. B., Kalwinsky, D. K., Raimondi, S., Kitchingman, G. R., and Mirro, J. Acute myeloid leukemia with T-lymphoid features: a distinct biologic and clinical entity. Blood, 72: 579–587, 1988.
37. Januszewicz, E. H. Bridging the gap between acute lymphoid and acute myeloid leukemias. Med. J. Aust., 146:614–615, 1987.
38. Philip, I., Philip, T., Favrot, M., Vuillaume, M., Fontaiere, B., Chamard, D., and Lenoir, G. M. Establishment of lymphomatous cell lines from bone marrow samples from patients with Burkitt's lymphoma. J. Natl. Cancer Inst., 75:835–840, 1984.
39. Mark-Vendel, E., Philip, I., Philip, T., Lenoir, G., Berger, R., and Mitelman, F. Cytogenetic evaluation of bone marrow involvement in Burkitt's lymphoma. Leuk., Res., 72: 263–265, 1988.
40. Saltman, D. L., Cachia, P. G., Dewar, A. E., Ross, F. M., Krajewski, A. S., Ludlam, C., and Steel, C. M. Characterization of a new non-Hodgkin lymphoma cell line (NCEB-1) with chromosomal (11:14) translocation [t(ll:14)(ql3:q32)]. Blood, 72:2026–2030, 1988.
41. Miyoshi, I., Kubonishi, I., Yoshimoto, S., Hikita, T., Dabasaki, H., Tanaka, T., Kimura, I., Tabuchi, K., and Nishimoto, A. Characteristics of a brain lymphoma cell line derived from primary intracranial lymphoma. Cancer (Phila.), 49:456–459, 1982.
42. McCune, J. M., Namikawa, R., Kaneshima, H., Shultz, L. D., Lieberman, M., and Weissman, I. L. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science (Wash. DC), 241:1632–1639, 1988.
43. Mosier, D. E., Gulizia, R. J., Baird, S. M., and Wilson, D. B. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature (Lond.), 335: 256–259, 1988.
44. Poiesz, B. J., Ruscetti, F. W., Mier, J. W., Woods, A. M., and Gallo, R. C. T-cell lines established from human T-lymphocytic neoplasias by direct response to T-cell growth factor. Proc. Natl. Acad. Sci. USA, 77: 6815–6819, 1980.
45. Chen, I. S. Y., Quan, S. G., and Golde, D. W. Human T-cell leukemia virus type II transforms normal human lymphocytes. Proc. Natl. Acad. Sci. USA, 80:7006–7009, 1983.
46. Estrov, Z., Grunberger, T., Dube, I. D., Wang, Y., and Freedman, M. H. Detection of residual acute lymphoblastic leukemia cells in cultures of bone marrow obtained during remission. N. Engl. J. Med., 315: 538–542, 1986.
47. Smith, S. D., Wood, G. W., Fried, P., and Lowman, J. T. In vitro growth of lymphoma colonies from children with non-Hodgkin's lymphoma. Cancer (Phila.), 48: 2612–2623, 1981.
48. Kees, U. R. Resistance to 1–0-D-arebinofuranosylcytosine after high dose treatment in childhood lymphoblastic leukemia: isolation of a drug resistant and a sensitive line. Cancer Res., 47: 3088–3091.
49. Anderson, M., Klein, G., Ziegler, J. L., and Henle, W. Association of Epstein-Barr viral genomes with American Burkitt lymphoma. Nature (Lond.), 260: 357–359, 1976.